Endorsed NICE Technology Appraisals 2010/2011

Topics:

Date published: 24 March 2011

Endorsed NICE Technology Appraisals 2010/2011

The following NICE Technology Appraisals were endorsed by DoH during 2010/2011

Documents

National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA171 - Lenalidomide for Multiple Myeloma - HSC (SQSD) (NICE) 06/2010Adobe PDF (330.82 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA176 - Cetuximab for the First-line Treatment of Metastatic Colorectal Cancer - HSC (SQSD) (NICE) 14/2010Adobe PDF (346.36 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA177 - Alitretinoin for the Treatment of Severe Chronic Hand Eczema - HSC (SQSD) (NICE) 15/2010Adobe PDF (343.23 KB)
(NICE) Technology Appraisal TA178 - Bevacizumab (first-line), Sorafenib (first and second-line), Sunitinib (second-line) and Temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma - HSC(SQSD) (NICE) 16/2010Adobe PDF (329.49 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA179 - Sunitinib for the Treatment of Gastrointestinal Stromal Tumours - HSC (SQSD) 17/2010Adobe PDF (337.5 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA180 - Ustekinumab for the Treatment of Adults with Moderate to Severe Psoriasis - HSC (SQSD) (NICE) 18/2010Adobe PDF (338.98 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA181 - Pemetrexed for the First-Line Treatment of Non-Small-Cell Lung Cancer - HSC (SQSD) (NICE) 19/2010Adobe PDF (333.38 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA182 - Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention - HSC (SQSD) (NICE) 10/2010Adobe PDF (333.96 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA183 - Topotecan for the treatment of recurrent carcinoma of the cervix - HSC (SQSD) (NICE) 11/2010Adobe PDF (328.35 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA184 - Topotecan for the treatment of relapsed small-cell lung cancer - HSC (SQSD) (NICE) 12/2010Adobe PDF (333.09 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA196 - Imatinib for the Adjuvant Treatment of Gastrointestinal Stromal Tumours - HSC (SQSD) (NICE) 11/2011Adobe PDF (330.63 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA210 - Clopidogrel and Modified-Release Dipyridamole for the Prevention of Occular Vascular Events - HSC (SQSD) (NICE) 12/2011Adobe PDF (340.84 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA211 - Prucalopride for the Treatment of Chronic Constipation in Women - HSC (SQSD) (NICE) 06/2011Adobe PDF (318.61 KB)